Buch, Englisch, 301 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 1380 g
Buch, Englisch, 301 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 1380 g
ISBN: 978-3-540-43082-7
Verlag: Springer Berlin Heidelberg
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Allergologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Umweltmedizin, Arbeitsmedizin, Tropenmedizin, Sportmedizin Umweltmedizin
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Dermatologie
Weitere Infos & Material
1 Pollen Grains Contain and Release Not Only Allergens, but Also Eicosanoid-Like Substances with Neutrophil Chemotactic Activity: A New Step in the Initiation of Allergie Sensitization?.- 2 House Dust Mites in Stuffed Toys as a Cause of Allergy in Lithuania.- 3 Pharmacogenetics of ?2-Adrenoceptor and Asthmatic Phenotypes.- 4 Pertussis Vaccination Is Not Associated with a Higher Prevalence of Allergies in Six-Year-Old Children from West Germany.- 5 Human Allergogeneticists Should Listen to Their Dog’s Barking.- 6 Neuro-Immune Interaction in Allergy and Asthma.- 7 Cadherin Biology of Langerhans Cells.- 8 CD8 T Cell-Dendritic Cell (DC) Interaction in the Regulation of IgE.- 9 MHC Class II-Restricted T Cell Activation by Mouse and Human Mast Cells: Potential Clinical Implications.- 10 T Cell Reactivity Against Timothy Grass Pollen Allergens in Allergie Versus Non-Allergie Human Donors: Epitope Recognition and Cytokine Profile.- 11 ?1,3-Fucosyltransferase VII mRNA Expression Is Induced by Superantigens and Blocked by Inhibitors of NF-?B.- 12 Dendritic Cells and Tolerance.- 13 Eosinophils Maintain Their Capacity to Degranulate upon Repetitive Stimulation with the Same Agonist.- 14 Mast Cells as Initiators and Effectors of Allergie Inflammation.- 15 Modulation of Skin Barrier Function.- 16 T Cells and Effector Mechanisms in Atopic Dermatitis.- 17 Material-Odor Analysis as a Prerequisite for the Allergological Evaluation of Outgassing Odoractive Volatile Compounds.- 18 The Atopy Patch Test: Use and Perspectives.- 19 The Intrinsic Type of Atopic Dermatitis Is Characterised by a Low Expression of the High-Affinity IgE Receptor F??RI on Epidermal Dendritic Cells.- 20 Staphylococcal Exotoxins as Trigger Factors of Atopic Dermatitis.- 21 Peanut Allergy: Are Clinical SymptomsAssociated with IgE-Reactivity to Certain (Recombinant) Peanut Allergens?.- 22 Challenge Tests with Food Additives and Aspirin in the Diagnostics of Chronic Urticaria. A Case of Immediate Cutaneous Hypersensitivity to Sodium Bisulphite (E-222) Confirmed by Patch Testing.- 23 Serum Sickness as a Clinical Model for Food Intolerance.- 24 Role of Tryptase in Anaphylaxis.- 25 Practical Approach to Adverse Food Reactions.- 26 Multiple Chemical Sensitivity and Others: Allergological, Environmentaland Psychological Investigations in Individuals with Indoor Air-Related Complaints.- 27 Latex Allergens and Latex Allergy.- 28 Long-Term Course of Natural Rubber Latex Sensitization and Allergy.- 29 Long-Term Continuous Antiallergic Treatment Reduces Symptoms and Controls Allergie Inflammation Better than Symptomatic Treatment.- 30 Rapid Onset and Sustained Efficacy of Desloratadine in Treatment of Chronic Idiopathic Urticaria.- 31 Preclinical Efficacy and Antiallergic Profile of Desloratadine, a Potent Histamine H1-Receptor Antagonist.- 32 Desloratadine Is Effective at Relieving Nasal Congestion, as Demonstrated in Three Placebo-Controlled Trials in Patients with Seasonal Allergie Rhinitis.- 33 Novel Concepts on Allergie Rhinitis: From Pathogenesis to Treatment.- 34 CpG Oligodeoxynucleotides and Their Potential Role in the Immunotherapy of Allergie Diseases.- 35 Allergen 3-D Structure-Based Design of Future Vaccines for Specific Allergy Vaccination.- 36 Immunological Mechanisms of Anti-IgE Treatment.